About 4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one
4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one (PubChem CID 154752541) has the molecular formula C16H16N4O2
and a molecular weight of 296.33 g/mol. Its IUPAC name is 4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one.
Analyze 4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one?
The IUPAC name of 4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one (CID 154752541) is 4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one.
What is the SMILES notation for 4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one?
The canonical SMILES for 4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one is Cn1nc(-c2nnc(C3CC3(C)C)o2)c2ccccc2c1=O.
What is the InChIKey of 4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one?
The InChIKey is HNDHMAPQNXTAMV-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H16N4O2/c1-16(2)8-11(16)13-17-18-14(22-13)12-9-6-4-5-7-10(9)15(21)20(3)19-12/h4-7,11H,8H2,1-3H3.
What are the key properties of 4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one?
4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one has a molecular weight of 296.33 g/mol, XLogP of 2.50, 2 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-(2,2-dimethylcyclopropyl)-1,3,4-oxadiazol-2-yl]-2-methylphthalazin-1-one is sourced from PubChem (CID 154752541), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).